SEC Form 4 · Rule 10b5-1 trading plans
Regulus Therapeutics Inc. (RGLS)
- 7Trades filed under a plan
- 0Plan adoption dates stated
- 0Quarterly results prints on file
- 0Trades in the days before a print
In the 2025 filing year, Regulus Therapeutics Inc. filed 4 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 4 reporting owners, covering 7 transactions filed under those plans and 245,938 shares. 4 of those filings carry the SEC's own AFF10B5ONE adoption flag; the other 0 name a plan in a footnote and carry no flag. No results print is on file in this window, so no interval is measured.
Trades filed under a plan in Regulus Therapeutics Inc. 7
- Aker Christopher Ray — 2025-01-13 · S · 38,547 shares
- CALSADA CRISPINA — 2025-01-13 · S · 38,716 shares
- Hagan Joseph P — 2025-01-13 · S · 115,290 shares
- Klassen Preston — 2025-01-13 · S · 31,445 shares
- Aker Christopher Ray — 2025-01-14 · S · 5,088 shares
- CALSADA CRISPINA — 2025-01-14 · S · 5,088 shares
- Hagan Joseph P — 2025-01-14 · S · 11,764 shares
Plan adoption dates stated in Regulus Therapeutics Inc. 0
Quarterly results prints on file in Regulus Therapeutics Inc. 0
Trades in the days before a print in Regulus Therapeutics Inc. 0
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 0Within 5 days of a print
- 0Within 10 days of a print
- —Shortest interval, in days
- 7Trades with no later print on file
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.